Work

A phase 1 study of dinaciclib (SCH 727965) in combination with epirubicinin patients with metastatic triple-negative breast cancer.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.26_suppl.163

Authors: Zahi Mitri, Kansu Karakas, Nuhad K. Ibrahim, Ricardo H. Alvarez, James L. Murray, Brian Briones, Holly Simmons, Khandan Keyomarsi, Stacy L. Moulder

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2229660774

Cites:

Cited by: 3

Related to: 10